Clinicopathological variables | N | DMRT(%) | DMRN(%) | DMRT/DMRN | ||||
---|---|---|---|---|---|---|---|---|
Mean rank | p value | Mean rank | p value | Mean rank | p value | |||
Gender | Male | 78 | 61.33 | 0.122 | 56.72 | 0.001* | 73.59 | 0.003* |
 | Female | 52 | 71.76 |  | 78.66 |  | 53.37 |  |
Age (years) | ≤60 | 49 | 57.32 | 0.054 | 64.21 | 0.762 | 60.98 | 0.287 |
 | >60 | 81 | 70.45 |  | 66.28 |  | 68.23 |  |
Maximum Size (cm) | ≤5 | 93 | 64.68 | 0.693 | 66.60 | 0.599 | 64.74 | 0.716 |
 | >5 | 37 | 67.57 |  | 62.74 |  | 67.41 |  |
Locationa | Left side | 62 | 59.76 | 0.097 | 62.07 | 0.322 | 64.48 | 0.769 |
 | Right side | 68 | 70.74 |  | 68.63 |  | 66.43 |  |
Differentiation | G1-G2 | 87 | 68.45 | 0.204 | 66.78 | 0.581 | 65.34 | 0.947 |
 | G3-G4 | 43 | 59.53 |  | 62.91 |  | 65.81 |  |
Mucinous or signet-ring carcinoma | No | 103 | 67.98 | 0.701 | 64.97 | 0.754 | 66.53 | 0.541 |
 | Yes | 27 | 64.85 |  | 67.52 |  | 61.56 |  |
CEA | Normal | 59 | 58.58 | 0.056 | 58.43 | 0.051 | 64.86 | 0.859 |
 | Elevated | 71 | 71.25 |  | 71.37 |  | 66.04 |  |
Tumor (T) stage | T1-2 | 20 | 64.84 | 0.640 | 64.82 | 0.631 | 64.46 | 0.460 |
 | T3-4 | 110 | 69.13 |  | 69.23 |  | 71.23 |  |
Nodal (N) status | N0 | 63 | 66.97 | 0.216 | 65.76 | 0.275 | 68.72 | 0.595 |
 | N1-2 | 66 | 62.32 |  | 64.93 |  | 58.50 |  |
Distant metastases (M)b | M0 | 101 | 65.20 | 0.865 | 61.26 | 0.017* | 69.18 | 0.037* |
 | M1 | 29 | 66.55 |  | 80.26 |  | 52.67 |  |
AJCC stage | I-II | 59 | 64.54 | 0.754 | 66.37 | 0.776 | 61.56 | 0.198 |
 | III-IV | 71 | 66.62 |  | 64.48 |  | 70.09 |  |
Lymphovascular invasion | No | 89 | 66.97 | 0.513 | 65.76 | 0.906 | 68.72 | 0.150 |
 | Yes | 41 | 62.32 |  | 64.93 |  | 58.50 |  |
Perineural invasion | No | 109 | 65.61 | 0.939 | 64.28 | 0.398 | 67.35 | 0.202 |
 | Yes | 21 | 64.93 |  | 71.86 |  | 55.90 |  |
Extranodal tumor deposits | No | 107 | 65.83 | 0.831 | 65.08 | 0.786 | 66.34 | 0.585 |
 | Yes | 23 | 63.98 |  | 67.43 |  | 61.61 |  |